Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Add AVACTA GROUP PLC to Feed

AVACTA GROUP PLC

About AVACTA GROUP PLC

Avacta Group plc is a life sciences company with a focus on improving healthcare and well-being through innovative oncology drugs and diagnostics. The company operates through two divisions, Diagnostics and Therapeutics. The Therapeutics Division is developing a pipeline of novel Affimer® immunotherapies and pre|CISION™ tumour targeted chemotherapies to address challenges in cancer treatment. The Diagnostics Division supplies in-vitro diagnostic solutions, growing rapidly through an M&A strategy to become a global scale IVD business offering market-leading healthcare solutions. The company's research and development center uses the proprietary Affimer® platform to differentiate immunodiagnostic products, enhancing their performance. ...

Latest news & discussion for AVACTA GROUP PLC:

1

1

AVACTA GROUP PLC Update on Convertible Bond Payment and Corporate Objectives for Avacta Group PLC

Posted by AssetRoom | 4 months ago | 0 comments

2

1

AVACTA GROUP PLC Avacta Group PLC Annual General Meeting Results Summary

Posted by AssetRoom | 5 months ago | 0 comments

3

1

AVACTA GROUP PLC Avacta Group PLC Provides Business Update and Announces Scientific Advisory Board

Posted by AssetRoom | 5 months ago | 0 comments

4

1

AVACTA GROUP PLC Avacta Group PLC Appoints Shaun Chilton as Non-Executive Chairman and Announces Board Evolution

Posted by AssetRoom | 5 months ago | 0 comments

5

1

AVACTA GROUP PLC Avacta Group PLC Appoints Peel Hunt LLP as Nominated Adviser and Sole Broker

Posted by AssetRoom | 6 months ago | 0 comments

6

1

AVACTA GROUP PLC Avacta Group PLC Announces Posting of Annual Report and Notice of AGM

Posted by AssetRoom | 6 months ago | 0 comments

7

1

AVACTA GROUP PLC Avacta Group PLC Announces Successful Completion of First Cohort and Dosing of Second Cohort in AVA6000 Phase 1 Trial

Posted by AssetRoom | 6 months ago | 0 comments

8

1

AVACTA GROUP PLC Avacta Group PLC Preliminary Results for the Year Ended 31 December 2023 and Appointment of New CEO

Posted by AssetRoom | 7 months ago | 0 comments

9

1

AVACTA GROUP PLC Avacta Group PLC Appoints Christina Coughlin as Chief Executive Officer

Posted by AssetRoom | 7 months ago | 0 comments

10

1

AVACTA GROUP PLC Avacta Group PLC Amends Block Listing Six Monthly Return

Posted by AssetRoom | 7 months ago | 0 comments

11

1

AVACTA GROUP PLC Avacta Group PLC Announces Block Listing Six Monthly Return

Posted by AssetRoom | 7 months ago | 0 comments

12

1

AVACTA GROUP PLC Avacta Group PLC Announces Block Listing Application to AIM

Posted by AssetRoom | 7 months ago | 0 comments

13

1

AVACTA GROUP PLC Avacta Group PLC to Announce Audited Preliminary Results for Year Ended 31st December 2023 and Deliver Investor Presentation via Investor Meet Company

Posted by AssetRoom | 7 months ago | 0 comments

14

1

AVACTA GROUP PLC Avacta Group PLC Issues Equity and Provides Total Voting Rights Summary

Posted by AssetRoom | 7 months ago | 0 comments

15

1

AVACTA GROUP PLC Avacta Group PLC Reports Positive Interim Results from Phase 1 Clinical Trial of AVA6000 at AACR Annual Meeting

Posted by AssetRoom | 8 months ago | 0 comments

16

1

AVACTA GROUP PLC Avacta Group PLC to Present AVA6000 Abstract at AACR Annual Meeting in San Diego

Posted by AssetRoom | 8 months ago | 0 comments

17

1

AVACTA GROUP PLC Avacta Group PLC to Host Investor Webinar on Updated Clinical Data for AVA6000

Posted by AssetRoom | 8 months ago | 0 comments

18

1

AVACTA GROUP PLC Update on AVA6000 Phase 1a Clinical Trial Progress for Avacta Group PLC

Posted by AssetRoom | 8 months ago | 0 comments

19

1

AVACTA GROUP PLC Avacta Group PLC Raises Approximately £31.1m in Fundraise

Posted by AssetRoom | 9 months ago | 0 comments

20

1

AVACTA GROUP PLC Avacta Group PLC to Present Updated Results from Phase 1 Clinical Trial of AVA6000 at AACR Annual Meeting

Posted by AssetRoom | 9 months ago | 0 comments

21

1

AVACTA GROUP PLC Avacta Group PLC Announces Result of REX Retail Offer and Fundraising Summary

Posted by AssetRoom | 9 months ago | 0 comments

22

1

AVACTA GROUP PLC Avacta Group PLC Successfully Completes Placing and Subscription

Posted by AssetRoom | 9 months ago | 0 comments

23

1

AVACTA GROUP PLC Avacta Group PLC Announces Proposed REX Retail Offer

Posted by AssetRoom | 9 months ago | 0 comments

24

1

AVACTA GROUP PLC Avacta Group PLC Announces Proposed Fundraise to Progress Therapeutics Division Pipeline

Posted by AssetRoom | 9 months ago | 0 comments

25

1

AVACTA GROUP PLC Avacta Group PLC Announces Share Incentive Plan and Issue of Equity

Posted by AssetRoom | 10 months ago | 0 comments